2023 Q4 Form 10-Q Financial Statement

#000149315223041055 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.000M $700.0K
YoY Change 42.86% -78.79%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $100.0K $0.00
YoY Change
% of Gross Profit
Operating Expenses $1.000M $700.0K
YoY Change 42.86% -78.79%
Operating Profit -$1.000M -$700.0K
YoY Change 42.86% -75.0%
Interest Expense $100.0K
YoY Change -150.0%
% of Operating Profit
Other Income/Expense, Net -$100.0K -$100.0K
YoY Change 0.0% -125.0%
Pretax Income -$1.100M -$800.0K
YoY Change 37.5% -74.19%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.100M -$800.0K
YoY Change 37.5% -71.43%
Net Earnings / Revenue
Basic Earnings Per Share -$41.67 -$30.30
Diluted Earnings Per Share -$41.67 -$30.30M
COMMON SHARES
Basic Shares Outstanding 25.17K shares 25.17K shares 25.17K shares
Diluted Shares Outstanding 26.40K shares 26.40K shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.100M $1.900M
YoY Change 63.16% 46.15%
Cash & Equivalents $3.100M $1.900M
Short-Term Investments
Other Short-Term Assets $1.000M
YoY Change
Inventory
Prepaid Expenses
Receivables $100.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $4.100M $2.000M
YoY Change 105.0% 11.11%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $12.50M $12.80M
YoY Change -2.34% 0.0%
Other Assets $600.0K $500.0K
YoY Change 20.0% 150.0%
Total Long-Term Assets $19.20M $13.30M
YoY Change 44.36% -37.56%
TOTAL ASSETS
Total Short-Term Assets $4.100M $2.000M
Total Long-Term Assets $19.20M $13.30M
Total Assets $23.30M $15.30M
YoY Change 52.29% -33.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.400M $1.300M
YoY Change 7.69% -53.57%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.200M $1.700M
YoY Change 29.41% -84.68%
LONG-TERM LIABILITIES
Long-Term Debt $15.10M $3.600M
YoY Change 319.44% 12.5%
Other Long-Term Liabilities $200.0K
YoY Change 0.0%
Total Long-Term Liabilities $15.10M $200.0K
YoY Change 7450.0% -94.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.200M $1.700M
Total Long-Term Liabilities $15.10M $200.0K
Total Liabilities $17.50M $5.500M
YoY Change 218.18% -84.93%
SHAREHOLDERS EQUITY
Retained Earnings -$1.042B -$1.038B
YoY Change 0.39%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $24.90M $24.90M
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $5.800M $9.800M
YoY Change
Total Liabilities & Shareholders Equity $23.30M $15.30M
YoY Change 52.29% -33.77%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$1.100M -$800.0K
YoY Change 37.5% -71.43%
Depreciation, Depletion And Amortization $100.0K $0.00
YoY Change
Cash From Operating Activities -$1.700M -$700.0K
YoY Change 142.86% -65.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$6.200M $0.00
YoY Change -100.0%
Cash From Investing Activities -$6.200M $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.80M 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -1.700M -700.0K
Cash From Investing Activities -6.200M 0.000
Cash From Financing Activities 10.80M 0.000
Net Change In Cash 2.900M -700.0K
YoY Change -514.29% -240.0%
FREE CASH FLOW
Cash From Operating Activities -$1.700M -$700.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001014111
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
usd
CY2022Q4 GLAE Mortgage Servicing Rights
MortgageServicingRights
usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
usd
CY2022Q4 GLAE Stock Rights
StockRights
usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
us-gaap Payments For Proceeds From Mortgage Servicing Rights
PaymentsForProceedsFromMortgageServicingRights
usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
usd
GLAE Proceeds From Sale Of Restricted Stock
ProceedsFromSaleOfRestrictedStock
usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
GLAE Marketable Securities Received From Distribution
MarketableSecuritiesReceivedFromDistribution
usd
GLAE Offset Accounts Receivable From Arrive Vs Capital Contribution Due Arrive
OffsetAccountsReceivableFromArriveVsCapitalContributionDueArrive
usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
usd
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
usd
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
usd
CY2022Q3 GLAE Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Acquired
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAcquired
usd
GLAE Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Acquired
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAcquired
usd
CY2023Q3 GLAE Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Orginations
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOrginations
usd
CY2022Q3 GLAE Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Orginations
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOrginations
usd
GLAE Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Orginations
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOrginations
usd
GLAE Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Orginations
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOrginations
usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
usd
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
usd
CY2023Q3 GLAE Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Changes In Fair Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetChangesInFairValue
usd
CY2022Q3 GLAE Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Changes In Fair Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetChangesInFairValue
usd
GLAE Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Changes In Fair Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetChangesInFairValue
usd
GLAE Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Changes In Fair Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetChangesInFairValue
usd
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
usd
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-14310
dei Entity Registrant Name
EntityRegistrantName
GLASSBRIDGE ENTERPRISES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1838504
dei Entity Address Address Line1
EntityAddressAddressLine1
18 East 50th Street
dei Entity Address Address Line2
EntityAddressAddressLine2
FL7
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
dei City Area Code
CityAreaCode
(212)
dei Local Phone Number
LocalPhoneNumber
220-3300
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25170 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
100000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1000000.0 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
700000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3200000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2300000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1000000.0 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
700000 usd
us-gaap Operating Expenses
OperatingExpenses
3200000 usd
us-gaap Operating Expenses
OperatingExpenses
2300000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1000000.0 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-700000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3100000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2300000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
100000 usd
us-gaap Interest Expense
InterestExpense
200000 usd
us-gaap Interest Expense
InterestExpense
200000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-100000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
200000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-100000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-100000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-200000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1100000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-800000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3300000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2300000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1100000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-800000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3300000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2300000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-41.67
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-41.67
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-30.30
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-30.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-125.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-125.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-87.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-87.12
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26400 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26400 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26400 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26400 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26400 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26400 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26400 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26400 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3100000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1200000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
100000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1000000.0 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
4100000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1300000 usd
CY2023Q3 GLAE Mortgage Servicing Rights
MortgageServicingRights
6100000 usd
CY2023Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
12500000 usd
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
12800000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
600000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
500000 usd
CY2023Q3 us-gaap Assets
Assets
23300000 usd
CY2022Q4 us-gaap Assets
Assets
14600000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1400000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1200000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
800000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
400000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2200000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1600000 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
1900000 usd
CY2023Q3 GLAE Stock Rights
StockRights
13200000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
3700000 usd
CY2023Q3 GLAE Deferred Taxes Liabilities Noncurrent
DeferredTaxesLiabilitiesNoncurrent
200000 usd
CY2022Q4 GLAE Deferred Taxes Liabilities Noncurrent
DeferredTaxesLiabilitiesNoncurrent
200000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
17500000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
5500000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28097 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28097 shares
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1073000000.0 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1073000000.0 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1042300000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1039000000.0 usd
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2927 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2927 shares
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
24900000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
24900000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5800000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
9100000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23300000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14600000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
9100000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3300000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1300000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-1300000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5800000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
12100000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
12100000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2300000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9800000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9800000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3300000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2300000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
200000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
200000 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-300000 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-100000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2700000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2000000.0 usd
us-gaap Payments For Proceeds From Mortgage Servicing Rights
PaymentsForProceedsFromMortgageServicingRights
5500000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
700000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
200000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6200000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-200000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2000000.0 usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
12700000 usd
GLAE Proceeds From Sale Of Restricted Stock
ProceedsFromSaleOfRestrictedStock
100000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1300000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1300000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4000000.0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10800000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1900000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2200000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1200000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4100000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3100000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1900000 usd
us-gaap Interest Paid Net
InterestPaidNet
600000 usd
us-gaap Interest Paid Net
InterestPaidNet
100000 usd
GLAE Marketable Securities Received From Distribution
MarketableSecuritiesReceivedFromDistribution
300000 usd
GLAE Offset Accounts Receivable From Arrive Vs Capital Contribution Due Arrive
OffsetAccountsReceivableFromArriveVsCapitalContributionDueArrive
100000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1360 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1100000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-800000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3300000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2300000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26400 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26400 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26400 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26400 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26400 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26400 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26400 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26400 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-41.67
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-41.67
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-30.30
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-30.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-125.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-125.00
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
2100000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-87.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-87.12
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1000000.0 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
800000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
600000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
200000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
400000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
200000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
200000 usd
CY2023Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
12500000 usd
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
12800000 usd
us-gaap Management Fee Description
ManagementFeeDescription
the Company is entitled to receive between 18% and 20% of all general partner consideration on pooled investment vehicles managed by Arrive, whether characterized as management fees or incentive fees
CY2023Q3 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
600000 usd
CY2022Q4 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
500000 usd
GLAE Marketable Securities Received From Distribution
MarketableSecuritiesReceivedFromDistribution
300000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
2100000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
3900000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
2100000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-700000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3100000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2300000 usd
CY2023Q3 us-gaap Assets
Assets
23300000 usd
CY2022Q4 us-gaap Assets
Assets
14600000 usd
us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
50000 usd
CY2023Q3 GLAE Percentage Of Prepayment Rates
PercentageOfPrepaymentRates
0.125 pure
CY2023Q3 GLAE Percentage Of Discount Rates
PercentageOfDiscountRates
0.0388 pure
GLAE Cost To Service
CostToService
81000000.00 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1360 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
106.00
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1360 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
106.00
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1360 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
106.00
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1360 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0.0 usd
CY2023Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0.0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0.0 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1100000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-800000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0.0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0.0 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-3300000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-2300000 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
GLAE Redeemable Preferred Stock And Restricted Stock Units
RedeemablePreferredStockAndRestrictedStockUnits
<p id="xdx_80A_ecustom--RedeemablePreferredStockAndRestrictedStockUnits_zz38LQSFf7aa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 10 — <span><span id="xdx_82D_zqqkyJmaVKk5">Redeemable Preferred Stock and Restricted Stock Units</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 25, 2023 (the “Closing Date”), the Company entered into a stock purchase agreement (the “Stock Purchase Agreement”) with Tacora. Pursuant to the terms of the Stock Purchase Agreement, on the Closing Date, the Company sold to Tacora <span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_dn_c20230923__20230925__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zCtLkrbDUnFa" title="Preferred stock, shares issued">13,725</span> shares of Series B Preferred Stock (the “Preferred Stock”), <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_dn_c20230923__20230925__us-gaap--StatementClassOfStockAxis__custom--Series1RestrictedStockMember_zb4GRcqjF0yh" title="Preferred stock, shares issued">7,500</span> Series 1 restricted stock units (the “Series 1 RSUs”), and <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_dn_c20230923__20230925__us-gaap--StatementClassOfStockAxis__custom--Series2RestrictedStockMember_zllrek4epFi9" title="Preferred stock, shares issued">15,000</span> Series 2 restricted stock units (the “Series 2 RSUs,” and together with the Series 1 RSUs, the “RSUs”). The Preferred Stock was purchased for $<span id="xdx_90F_eus-gaap--SharePrice_iI_c20230925__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zQCdHhd0V1Gf" title="Preferred stock price per share">1,000</span> per share, representing an aggregate sum of $<span id="xdx_90A_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn5n6_c20230923__20230925__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zjOxDXFH1Ki9" title="Preferred stock aggregate amount">13.7</span> million. The RSUs were purchased for $<span id="xdx_908_eus-gaap--SharePrice_iI_c20230925__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zaGeBB6EoG4i" title="Share price per unit">3.33</span> per unit, representing an aggregate sum of $<span id="xdx_900_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn5n6_c20230924__20230925__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zPMtOznlAGoa" title="Aggregate sum consideration">0.1</span> million. Under the Stock Purchase Agreement and subject to the terms and conditions set forth therein, Tacora also may purchase up to an additional <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230923__20230925__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zCa8zRaLBUUi" title="Number of shares issued">32,775</span> shares of Preferred Stock for aggregate consideration of $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn5n6_c20230923__20230925__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zPCj2PUPoX1j" title="Number of shares issued, value">32.8</span> million and up to an additional <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230923__20230925__us-gaap--StatementClassOfStockAxis__custom--Series1RestrictedStockMember_zsNPirVVGrEl" title="Number of shares issued">17,500</span> Series 1 RSUs and <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230923__20230925__us-gaap--StatementClassOfStockAxis__custom--Series2RestrictedStockMember_z5HK8fgUlTIb" title="Number of shares issued">35,000</span> Series 2 RSUs, for aggregate consideration of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn5n6_c20230924__20230925__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zlk7E5dWqWbi" title="Aggregate consideration">0.1</span> million. The additional shares of Preferred Stock and the RSUs will be purchased and issued from time to time, proportionally, in connection with and as the Company invests in certain approved transactions (as established in the Stock Purchase Agreement).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From the Closing Date until 48 months after all shares of Preferred Stock issuable to Tacora under the Stock Purchase Agreement have been issued, the Preferred Stock is entitled to receive cumulative dividend distributions at a rate of <span id="xdx_908_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20230101__20230930_zymikmdSffR9" title="Preferred dividend rate">8%</span> per annum. Thereafter, the dividend rate increases to <span id="xdx_90E_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_zJZoEHFJTafc" title="Preferred dividend rate">15.5%</span> per annum. The holders of the Preferred Stock have no voting rights and the Preferred Stock is not convertible into Common Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Mandatory Redemption of the Preferred Stock and RSUs</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each share of Preferred Stock is redeemable for $<span id="xdx_901_eus-gaap--SharePrice_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_zwG1f1uCcic7" title="Preferred stock redeemable per share">1,000</span> per share, plus all accrued and unpaid dividends thereon. The Company may redeem the Preferred Stock in part or in full at any time and from time to time; provided that the Company must redeem all of the issued and outstanding shares of Preferred Stock on or prior to the sixth anniversary of the Closing Date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning on the third anniversary of the Closing Date, Tacora has the right to surrender the Series 1 RSUs to the Company for a cash payment in an amount equal to the product of (i) the then <span id="xdx_908_ecustom--SurrenderOfSharesDescription_c20230101__20230930_z4fJXnGTgsD4" title="Surrender of shares, description">fair market value of a share of the Common Stock minus $164.95 (the estimated fair market value of a share of the Common Stock on the Closing Date) multiplied by (ii) the number of Series 1 RSUs then being surrendered to the Company</span>. Tacora has a similar right to surrender the Series 2 RSUs beginning on the sixth anniversary of Closing Date for a cash payment calculated in the same way. Neither the Company nor Tacora possess the right to deliver or demand that the RSUs be settled in Common Stock. The RSUs do not provide Tacora with voting rights or rights to dividend equivalent payments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company concluded the Preferred Stock and RSUs are mandatorily redeemable financial instruments in accordance with ASC 480 and, as such, must be classified as a liability, with preferred annual returns and any changes in redemption value being accrued and recorded as interest expense. The Company measured each of these liabilities at fair value on the Closing Date. As of September 30, 2023, the Company marked each of these financial instruments to the respective redemption value of $<span id="xdx_90B_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_iI_pn5n6_c20230930__us-gaap--ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis__us-gaap--ConvertiblePreferredStockSubjectToMandatoryRedemptionMember_zeY928OWgdc4">13.7</span> million for the preferred stock and $<span id="xdx_90A_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_iI_pn5n6_c20230930__us-gaap--ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis__us-gaap--RestrictedStockUnitsRSUMember_zH2lhtjUbULj">0.1</span> million for the RSUs, which is reflected on the consolidated balance sheets. The Company incurred $<span id="xdx_90F_eus-gaap--DeferredCosts_iI_pn5n6_c20230930_zIJaf3rjzY9j" title="Deferred issuance costs">0.6</span> million of deferred issuance costs in relation to the issuance of the Preferred Stock, which is presented net of the Preferred Stock liability and will be amortized over the estimated six-year term of the Preferred Stock. The Company did not incur material issuance costs related to the RSUs. As of September 30, 2023, the RSUs do not have any redemption value and the maximum amount payable for the preferred stock is $<span id="xdx_902_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_iI_pn5n6_c20230930__us-gaap--ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis__us-gaap--ConvertiblePreferredStockSubjectToMandatoryRedemptionMember__srt--RangeAxis__srt--MaximumMember_zaeeCmzHJVoh">13.7</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08 pure
GLAE Surrender Of Shares Description
SurrenderOfSharesDescription
fair market value of a share of the Common Stock minus $164.95 (the estimated fair market value of a share of the Common Stock on the Closing Date) multiplied by (ii) the number of Series 1 RSUs then being surrendered to the Company
CY2023Q3 us-gaap Deferred Costs
DeferredCosts
600000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1000000.0 usd
CY2023Q3 GLAE Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Acquired
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAcquired
6100000 usd
GLAE Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Acquired
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAcquired
6100000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
6100000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
6100000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
glae-20230930_cal.xml Edgar Link unprocessable
0001493152-23-041055-index-headers.html Edgar Link pending
0001493152-23-041055-index.html Edgar Link pending
0001493152-23-041055.txt Edgar Link pending
0001493152-23-041055-xbrl.zip Edgar Link pending
ex10-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
glae-20230930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
glae-20230930_def.xml Edgar Link unprocessable
glae-20230930_lab.xml Edgar Link unprocessable
glae-20230930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending